A personalised cancer vaccine has shown promising results in reducing the risk of melanoma returning or spreading after surgery.
Acral lentigenous melanoma of the toe. Acral lentiginous melanoma of the left hallux (ALM), Clark index IV in a 69-year-old man. [AFP]
A personalised cancer vaccine has shown promising results in reducing the risk of melanoma returning or spreading after surgery.
This marks a potential breakthrough in the treatment of high-risk skin cancer.
Premium Article
Get Full Access for Ksh299/Week.
If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.
An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year
A new personalised vaccine could halve the risk of skin cancer returning in high-risk patients, a large trial has found.
Patients with deadly skin cancer could soon benefit from a revolutionary vaccine that has been shown to slash the risk of their…
“It’s very exciting,” a melanoma expert said of the experimental cancer vaccine announced by pharmaceutical companies Moderna and…
Merck and Moderna said the vaccine helped prevent the return and spread of melanoma in a large trial involving more than 1,000…
